Patent Assignment
Reel/Frame 066553/0109
Release of Security Interest
Recorded: 2024-02-12
Pages: 34
Assignor
BIOPHARMA CREDIT PLC
Executed: 2024-02-12
Assignees
IMMUNOGEN, INC.
C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM, MASSACHUSETTS, 02451
IMMUNOGEN SWITZERLAND GMBH
BAARERSTRASSE 14, ZUG, 6300, SWITZERLAND
Covered Properties
(81)
Cytotoxic Agents Comprising New Maytansinoids
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates, and Methods of Making Said Conjugates
Methods for the Production of Ansamitocins
Method for the Preparation of Maytansinoid Esters
Method of Acylating Maytansinol with Chiral Amino Acids
Cytotoxic Agents Comprising New Maytansinoids
Cytotoxic Agents Comprising New Maytansinoids
Cytotoxic Agents Comprising New Maytansinoids
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Cross-Linkers and Their Uses
Methods for Preparation of Antibody-Maytansinoid Conjugates
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Cytotoxic Agents Comprising New Maytansinoids
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Methods for the Preparation of Charged Crosslinkers
Methods for Increasing Efficacy of FOLR1 Cancer Therapy
Cross-Linkers and Their Uses
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Diagnostic Assays and Kits for Detection of Folate Receptor 1
Methods for the Acylation of Maytansinol
Methods for the Preparation of Charged Crosslinkers
Cross-Linkers and Their Uses
Conjugation Methods
Monoclonal Antibodies for Detection of Folate Receptor 1
Anti-FOLR1 Immunoconjugate Dosing Regimens
Application:
14/509,809 →
Publication:
US 2015/0132323
Methods for the Preparation of Charged Crosslinkers
Methods for the Acylation of Maytansinol
Cross-Linkers and Their Uses
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Diagnostic Assays and Kits for Detection of Folate Receptor 1
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Methods for the Preparation of Charged Crosslinkers
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Conjugation Methods
Therapeutic Combinations Comprising Anti-FOLR1 Immunoconjugates
Methods for the Acylation of Maytansinol
Method of Targeting Specific Cell Populations Using Cell-Binding Agent Maytansinoid Conjugates Linked via a Non-Cleavable Linker, Said Conjugates and Methods of Making Said Conjugates
Methods of Treating Cancer in a Patient by Administering Anti-Folate-Receptor-1 (FOLR1) Antibodies
Methods for the Preparation of Charged Crosslinkers
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Diagnostic Assays and Kits for Detection of Folate Receptor 1
Methods for Preparing Antibody-Drug Conjugates
Methods for the Acylation of Maytansinol
Methods for Increasing Efficacy of FOLR1 Cancer Therapy
Maytansinoid Derivatives with Self-Immolative Peptide Linkers and Conjugates Thereof
Cross-Linkers and Their Uses
Anti-FOLR1 Immunoconjugates and Anti-Pd-1 Antibody Combinations
Application:
15/979,989 →
Publication:
US 2018/0333503
Methods of Using Antibodies to Detect Folate Receptor 1 (FOLR1)
Methods for the Acylation of Maytansinol
Therapeutic Combinations Comprising Anti-FOLR1 Immunoconjugates
Diagnostic Assays and Kits for Detection of Folate Receptor 1
Methods for Preparing Antibody-Drug Conjugates
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Methods for the Acylation of Maytansinol
Cross-Linkers and Their Uses
Maytansinoid Derivatives with Self-Immolative Peptide Linkers and Conjugates Thereof
A Method for Identifying an Ovarian Cancer in a Subject Likely to Respond to Anti-Folate Receptor 1 (FOLR1) Antibody
Biparatopic Fr-Alpha Antibodies and Immunoconjugates
Therapeutic Combinations Comprising Anti-FOLR1 Immunoconjugates
Application:
16/892,962 →
Publication:
US 2020/0397806
Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
Application:
16/934,143 →
Publication:
US 2021/0032327
Methods for Preparing a Purified Maytansinoid Conjugate in a Solution
Anti-FOLR1 Immunoconjugate Dosing Regimens
Application:
17/150,379 →
Publication:
US 2021/0155688
Anti-FOLR1 Immunoconjugates and Anti-Pd-1 Antibody Combinations
Application:
17/382,286 →
Publication:
US 2022/0160889
Maytansinoid Derivatives with Self-Immolative Peptide Linkers and Conjugates Thereof
Methods for Increasing Efficacy of FOLR1 Cancer Therapy
Application:
17/463,156 →
Publication:
US 2022/0143208
Method for Increasing the Efficacy of Cancer Therapy by Administering an Anti-FOLR1 Immunoconjugate
Therapeutic Combinations Comprising Anti-FOLR1 Immunoconjugates
Application:
17/651,459 →
Publication:
US 2022/0168326
Anti-FOLR1 Immunoconjugate Dosing Regimens
Application:
17/720,766 →
Publication:
US 2022/0378694
Treatment of Cancer in Patients with Soluble Fr-Alpha
Application:
17/831,085 →
Publication:
US 2023/0112620
Diagnostic Assays and Kits for Detection of Folate Receptor 1
Application:
17/831,254 →
Publication:
US 2023/0213524
Biparatopic Fr-Alpha Antibodies and Immunoconjugates
Conjugation Methods
Application:
17/964,168 →
Publication:
US 2023/0105468
Methods for Formulating Antibody Drug Conjugate Compositions
Application:
18/146,307 →
Publication:
US 2023/0364252
Methods for Detection of Folate Receptor 1 in a Patient Sample
Application:
18/179,207 →
Publication:
US 2023/0384329
Combination Therapy for Treatment of Ovarian Cancer
Application:
63/369,460 →
Combination Therapy for Treatment of Ovarian Cancer
Application:
63/383,603 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 20, 2004
From: CHARI, RAVI V.J.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 015362/0815 →
Assignment of Assignor's Interest
Oct 8, 2004
From: STEEVES, RITA; LUTZ, ROBERT; CHARI, RAVI; XIE, HONGSHENG
To: IMMUNOGEN, INC.
Reel/Frame 015911/0936 →
Assignment of Assignor's Interest
Apr 8, 2005
From: KUO, CYNTHIA; BYNG, GRAHAM S.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 016447/0844 →
Assignment of Assignor's Interest
Jan 19, 2006
From: WIDDISON, WAYNE C.; CHARI, RAVI V.J.
To: IMMUNOGEN, INC.
Reel/Frame 017487/0383 →
Assignment of Assignor's Interest
Jun 12, 2007
From: CHARI, RAVI V. J.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 019415/0051 →
Address Change
May 13, 2008
From: IMMUNOGEN, INC.
To: IMMUNOGEN, INC.
Reel/Frame 020930/0905 →
Assignment of Assignor's Interest
May 4, 2009
From: CHARI, RAVI V. J.; ZHAO, ROBERT YONGXIN; KOVTUN, YELENA; SINGH, RAJEEVA
To: IMMUNOGEN, INC.
Reel/Frame 022635/0807 →
Assignment of Assignor's Interest
Aug 18, 2010
From: KELLOGG, BRENDA A.; SINGH, RAJEEVA; CHARI, RAVI V. J.
To: IMMUNOGEN INC.
Reel/Frame 024856/0126 →
Assignment of Assignor's Interest
Jun 17, 2011
From: AB, OLGA; TAVARES, DANIEL; RUI, LINGYUN; PAYNE, GILLIAN
To: IMMUNOGEN, INC.
Reel/Frame 026454/0582 →
Assignment of Assignor's Interest
Jul 26, 2011
From: BLAETTLER, WALTER A.
To: IMMUNOGEN INC.
Reel/Frame 026651/0182 →
Assignment of Assignor's Interest
Aug 15, 2011
From: WIDDISON, WAYNE C.
To: IMMUNOGEN INC.
Reel/Frame 026749/0186 →
Assignment of Assignor's Interest
Aug 15, 2011
From: WIDDISON, WAYNE C.
To: IMMUNOGEN INC.
Reel/Frame 026749/0225 →
Assignment of Assignor's Interest
Oct 28, 2011
From: BLAETTLER, WALTER A.
To: IMMUNOGEN INC.
Reel/Frame 027143/0364 →
Assignment of Assignor's Interest
Mar 20, 2015
From: CHARI, RAVI V.J.; WIDDISON, WAYNE C.
To: IMMUNOGEN, INC.
Reel/Frame 035212/0719 →
Assignment of Assignor's Interest
Jun 30, 2016
From: MILLENNIUM PHARMACEUTICALS, INC.
To: IMMUNOGEN, INC.
Reel/Frame 039052/0987 →
Assignment of Assignor's Interest
Jun 30, 2016
From: CARROZZELLA, DARREN J.; HO, GUOJIE
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 039052/0966 →
Patent Security Agreement
Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →